Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men

被引:24
作者
Takaeko, Yuji [1 ]
Matsui, Shogo [1 ]
Kajikawa, Masato [2 ]
Maruhashi, Tatsuya [1 ]
Kishimoto, Shinji [1 ]
Hashimoto, Haruki [1 ]
Kihara, Yasuki [1 ]
Hida, Eisuke [3 ]
Chayama, Kazuaki [4 ]
Goto, Chikara [5 ]
Aibara, Yoshiki [6 ]
Yusoff, Farina Mohamad [6 ]
Noma, Kensuke [2 ,6 ]
Nakashima, Ayumu [7 ]
Higashi, Yukihito [2 ,6 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Div Regenerat & Med, Med Ctr Translat & Clin Res, Hiroshima, Japan
[3] Osaka Univ, Grad Sch Med, Dept Biostat & Data Sci, Osaka, Japan
[4] Hiroshima Univ, Dept Gastroenterol & Metab, Inst Biomed & Hlth Sci, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan
[5] Hiroshima Int Univ, Dept Physiol Therapy, Hiroshima, Japan
[6] Hiroshima Univ, Dept Cardiovasc Regenerat & Med, Res Inst Radiat Biol & Med, Hiroshima, Japan
[7] Hiroshima Univ, Grad Sch Biomed Sci, Dept Stem Cell Biol & Med, Hiroshima, Japan
关键词
High-density lipoprotein cholesterol; Endothelial function; Flow-mediated vasodilation; Men; Atherosclerosis; CORONARY-HEART-DISEASE; FLOW-MEDIATED DILATION; TRANSFER PROTEIN GENE; CARDIOVASCULAR EVENTS; HDL CHOLESTEROL; RISK-FACTOR; VASODILATION; DEFICIENCY; MORTALITY; COMMUNITY;
D O I
10.1016/j.jacl.2019.06.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: It is not clear whether a high level of high-density lipoprotein cholesterol (HDL-C) is associated with lower risk of atherosclerosis. It is likely that HDL-C is a double-edged sword for atherosclerosis. OBJECTIVE: The purpose of this study was to evaluate the relationship between HDL-C levels and endothelial function in men. METHODS: This was a cross-sectional study. We evaluated flow-mediated vasodilation (FMD) and serum levels of HDL-C in 5842 men aged 18 to 92 years who were not receiving lipid-lowering therapy. All participants were divided into four groups by HDL-C level: low HDL-C (<40 mg/dL), moderate HDL-C (40-59 mg/dL), high HDL-C (60-79 md/dL), and extremely high HDL-C (>= 80 mg/dL). We were not able to evaluate the amount of alcohol intake because there was limited information on the amount of alcohol drinking in our database. RESULTS: FMD values were significantly smaller in the low group and the extremely high group than in the high group (P = .001 and P = .016, respectively). There was no significant difference in FMD between the low group and the extremely high group. Multiple logistic regression analysis revealed that extremely high HDL-C, but not low HDL-C, was independently associated with the lowest quartile of FMD (odds ratio: 1.39, 95% confidence interval: 1.09-1.77; P = .009). CONCLUSIONS: An extremely high level of HDL-C in men (8.1% of this population) was associated with a significant reduction in FMD. (C) 2019 National Lipid Association. Published by Elsevier Inc.
引用
收藏
页码:664 / 672
页数:9
相关论文
共 56 条
[1]   Exercise Training in Patients with Chronic Heart Failure Promotes Restoration of High-Density Lipoprotein Functional Properties [J].
Adams, Volker ;
Besler, Christian ;
Fischer, Tina ;
Riwanto, Meliana ;
Noack, Friederike ;
Hoellriegel, Robert ;
Oberbach, Andreas ;
Jehmlich, Nico ;
Voelker, Uwe ;
Winzer, Ephraim B. ;
Lenk, Karsten ;
Hambrecht, Rainer ;
Schuler, Gerhard ;
Linke, Axel ;
Landmesser, Ulf ;
Erbs, Sandra .
CIRCULATION RESEARCH, 2013, 113 (12) :1345-+
[2]   Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene [J].
Agerholm-Larsen, B ;
Nordestgaard, BG ;
Steffensen, R ;
Jensen, G ;
Tybjærg-Hansen, A .
CIRCULATION, 2000, 101 (16) :1907-1912
[3]  
[Anonymous], 1999, Diabetes Care, V22 Suppl 1, pS1
[4]  
[Anonymous], 2017, N ENGL J MED
[5]   RELATION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDES TO INCIDENCE OF ATHEROSCLEROTIC CORONARY-ARTERY DISEASE (THE PROCAM EXPERIENCE) [J].
ASSMANN, G ;
SCHULTE, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (07) :733-737
[6]   Effects of torcetrapib in patients at high risk for coronary events [J].
Barter, Philip J. ;
Caulfield, Mark ;
Eriksson, Mats ;
Grundy, Scott M. ;
Kastelein, John J. P. ;
Komajda, Michel ;
Lopez-Sendon, Jose ;
Mosca, Lori ;
Tardif, Jean-Claude ;
Waters, David D. ;
Shear, Charles L. ;
Revkin, James H. ;
Buhr, Kevin A. ;
Fisher, Marian R. ;
Tall, Alan R. ;
Brewer, Bryan .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122
[7]   Clinical correlates and heritability of flow-mediated dilation in the community - The Framingham Heart Study [J].
Benjamin, EJ ;
Larson, MG ;
Keyes, MJ ;
Mitchell, GF ;
Vasan, RS ;
Keaney, JF ;
Lehman, BT ;
Fan, SX ;
Osypiuk, E ;
Vita, JA .
CIRCULATION, 2004, 109 (05) :613-619
[8]   Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease [J].
Besler, Christian ;
Heinrich, Kathrin ;
Rohrer, Lucia ;
Doerries, Carola ;
Riwanto, Meliana ;
Shih, Diana M. ;
Chroni, Angeliki ;
Yonekawa, Keiko ;
Stein, Sokrates ;
Schaefer, Nicola ;
Mueller, Maja ;
Akhmedov, Alexander ;
Daniil, Georgios ;
Manes, Costantina ;
Templin, Christian ;
Wyss, Christophe ;
Maier, Willibald ;
Tanner, Felix C. ;
Matter, Christian M. ;
Corti, Roberto ;
Furlong, Clement ;
Lusis, Aldons J. ;
von Eckardstein, Arnold ;
Fogelman, Alan M. ;
Luescher, Thomas F. ;
Landmesser, Ulf .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (07) :2693-2708
[9]   HDL levels and oxidizability during myocardial infarction are associated with reduced endothelial-mediated vasodilation and nitric oxide bioavailability [J].
Carvalho, Luiz Sergio F. ;
Panzoldo, Natalia ;
Santos, Simone N. ;
Modolo, Rodrigo ;
Almeida, Breno ;
Quinaglia e Silva, Jose C. ;
Nadruz-, Wilson, Jr. ;
de Faria, Eliana C. ;
Sposito, Andrei C. .
ATHEROSCLEROSIS, 2014, 237 (02) :840-846
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497